NYU Langone Hospital—Long Island’s pediatric hematologists care for children with a wide range of blood diseases. Utilizing in-house treatments and research programs as well as national collaborative group studies such as those of the Children’s Oncology Group (COG), The National Marrow Donor Program (NMDP), and others, our specialists provide some of the most advanced treatments available. Many patients on chronic transfusion therapy receive their treatment in a unique, outpatient setting that offers evening hours for patient convenience.
Our pediatric hematology and oncology specialists are part of a cutting-edge network of treatment and support systems that includes highly specialized centers and programs and the latest stem cell transplantation services.
In our ongoing commitment to treat, manage – and cure – childhood blood disorders, NYU Langone Cancer Center for Kids—Mineola is a member of the Thalassemia Clinical Research Network, which conducts active research and develops new treatments for patients with this inherited disorder. The Center also participates in the New York State Newborn Screening Program for hemoglobinopathy that detects and treats neonates with sickle cell and other similar disorders and is approved as a New York State Hemoglobinopathy Specialty Center.
Uniting some of the region’s best pediatric hematologists and pediatric oncologists, the Center evaluates, diagnoses and treats newborns, children, adolescents and young adults with a variety of childhood blood disorders including:
We also conduct screening tests for abnormal pre-surgical coagulation.